The effect of coenzyme Q10 supplement on Prevention of hepatotoxicity in patients with major ß-thalassemia
Phase 3
Recruiting
- Conditions
- Thalassemia.Beta thalassemiaD56.1
- Registration Number
- IRCT20221211056777N2
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with thalassemia major
Patients with thalassemia major with elevated liver enzymes
Patients with thalassemia major with elevated inflammation markers
Exclusion Criteria
Patients with active viral hepatitis
Hepatotoxic drugs consumption
Hypersplenism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method